Vivimed Labs has informed that it received approvals for the following 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site: Bilastine tablets 20mg under brand name FLUSTIN; Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI; and Paracetamol 12Smg/ Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL.
The above information is a part of company’s filings submitted to BSE.